TMIST Breast Screening Study
TMIST is a breast screening research study comparing standard digital mammography (2-D) with a newer technology called tomosynthesis mammography (3-D).
TMIST is a breast screening research study comparing standard digital mammography (2-D) with a newer technology called tomosynthesis mammography (3-D).
Join fellow researchers, data scientists, and patient advocates in the quest to enhance today’s collection and exchange of standardized cancer data.
Overview The 12th Annual Symposium on Global Cancer Research (ASGCR) will be held virtually May 6 – May 9, 2024 [8AM-12PM Eastern Time each day]. See…
The NCCR*Explorer is an interactive data investigation tool from the NCI that leverages data from NCCR registries. It provides incidence and survival statistics for cancers…
Diversity in clinical trials is critical for understanding how well a treatment may work in different populations. A new study describes representation based on sex,…
Hailey, a survivor of Hodgkin lymphoma, believes sharing data can help doctors and researchers understand the unique needs of underserved groups.
A clinical trial that has been running for 30 years leads to a highly effective treatment for the rare precancerous condition lymphomatoid granulomatosis.
Explore the many ways you can participate in cancer research, including treatment and non-treatment studies.
An international team of researchers has identified 50 new areas across the genome that are associated with the risk of developing kidney cancer.
The Oral Cancer Survival Calculator. This tool is for people who have recently been diagnosed with oral cancer, which affects about 38,000 people in the…
Join the NCI Office of Cancer Survivorship (OCS) for this OCS Director’s Series webinar on May 7. Dr. Veena Shankaran will present High-Quality Care Without…